AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

OPTISCAN IMAGING LIMITED

0.082

0.000

Volume:122.34K

Turnover:10.03K

Market Cap:68.50M

PE:-13.76

High:0.083

Open:0.082

Low:0.082

Close:0.082

52wk High:0.210

52wk Low:0.082

Shares:835.34M

Float Shares:437.75M

Volume Ratio:1.10

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.006

EPS(LYR):-0.007

ROE:-35.59%

ROA:-21.87%

PB:5.91

PE(LYR):-11.14

Loading ...

Overview Company News Filings

Optiscan Imaging Begins In-Human Breast Cancer Clinical Study

MT Newswires Live

ASX ALERT-Optiscan Initiates Breast Cancer Study in Melbourne-OIL.AX

Optiscan Imaging Enters Collaboration Agreement with US Firm for Applications for Imaging Contrast Agent, Shares Jump 9%

MT Newswires Live

BRIEF-Optiscan Imaging Signs Agreement With Long Grove Pharmaceuticals

Optiscan Imaging Ltd - Signs Agreement With Long Grove Pharmaceuticals

THOMSON REUTERS

Optiscan Imaging - Under Deal, Cos to Develop New Intended Uses for Long Grove's Intravenous Fluorescein Sodium Contrast Agent

THOMSON REUTERS

ASX ALERT-Optiscan Signs Agreement with Long Grove Pharmaceuticals-OIL.AX

Optiscan Imaging to Showcase Veterinary Imaging Device InSpecta at US Conference

MT Newswires Live

Optiscan Completes Minimum Viable Product Stage for Telepathology Streaming Software Project; Shares Rise 14%

MT Newswires Live

Optiscan Imaging Working on Robotic-Compatible Digital Endomicroscopic Imaging System. Shares Fall 9%

MT Newswires Live

BUZZ-Australia's Optiscan Imaging gains on Mayo clinic collaboration progress

BRIEF-Optiscan Imaging Says Progressing Robotic Surgery Collaboration With Mayo Clinic

Optiscan Imaging Ltd - Optiscan Progresses Robotic Surgery Collaboration With Mayo Clinic

THOMSON REUTERS

BRIEF-Optiscan Imaging Darius Ooi Promoted To Chief Financial Officer Role

Optiscan Imaging Promotes Finance Manager to CFO

MT Newswires Live

Optiscan Imaging - Darius Ooi Promoted to Chief Financial Officer Role

THOMSON REUTERS

Investors push Optiscan Imaging (ASX:OIL) 11% lower this week, company's increasing losses might be to blame

Simply Wall St.

Optiscan Imaging Launches New Medical Imaging Device For Pathology; Shares Up 7%

MT Newswires Live

Australian Vanadium Leads The Charge Among 3 ASX Penny Stocks

Simply Wall St.

Here's Why We're Not Too Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Situation

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OIL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OIL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OIL.AU\",,,,,undefined,":{"symbol":"OIL.AU","market":"AU","secType":"STK","nameCN":"OPTISCAN IMAGING LIMITED","latestPrice":0.082,"timestamp":1755497520000,"preClose":0.082,"halted":0,"volume":122335,"delay":0,"nameEN":"OPTISCAN IMAGING LIMITED","floatShares":437752412,"shares":835340803,"eps":-0.00596,"marketStatus":"Not Yet Opened","change":0,"latestTime":"08-18 16:12:00 AEST","open":0.082,"high":0.083,"low":0.082,"amount":10031,"amplitude":0.012195,"askPrice":0.085,"askSize":34071,"bidPrice":0.081,"bidSize":44645,"shortable":3,"etf":0,"ttmEps":-0.00596,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1755561600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.082,"openAndCloseTimeList":[[1755475200000,1755496800000]],"volumeRatio":1.0969033670241615,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OIL.AU\",,,,,undefined,":{"symbol":"OIL.AU","floatShares":437752412,"roa":"-21.87%","roe":"-35.59%","lyrEps":-0.007364,"volumeRatio":1.0969033670241615,"shares":835340803,"dividePrice":0,"high":0.083,"amplitude":0.012195,"preClose":0.082,"low":0.082,"week52Low":0.082,"pbRate":"5.91","psRate":"13.80","week52High":0.21,"institutionHeld":0,"latestPrice":0.082,"committee":0.134331,"eps":-0.00596,"divideRate":0,"volume":122335,"delay":0,"ttmEps":-0.00596,"open":0.082,"prevYearClose":0.155,"prevWeekClose":0.082,"prevMonthClose":0.105,"prevQuarterClose":0.11,"fiveDayClose":0.092,"twentyDayClose":0.115,"sixtyDayClose":0.115},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OIL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-06-01","symbol":"OIL.AU","defaultRemindTime":1685577600000,"type":"split","dateTimestamp":1685541600000,"forFactor":979885,"toFactor":1000000,"ratio":0.979885}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OIL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OIL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2547054863","title":"Optiscan Imaging Begins In-Human Breast Cancer Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2547054863","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547054863?lang=en_us&edition=fundamental","pubTime":"2025-06-30 14:44","pubTimestamp":1751265881,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  began its first in-human breast cancer clinical study at the Royal Melbourne Hospital to assess surgical margins in patients receiving treatment for breast cancer using its imaging devices, according to a Monday Australian bourse filing.The 50-patient study will welcome patients for recruitment for in vivo clinical assessment of breast cancer margins following a lumpectomy procedure. It will use Optiscan's InVue precision surgery and InForm digital pathology imaging devices.The study completed site initiation.It will use the data for submissions to the US Food and Drug Administration.The firm's shares jumped 10% on market close on Monday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2547058572","title":"ASX ALERT-Optiscan Initiates Breast Cancer Study in Melbourne-OIL.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2547058572","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547058572?lang=en_us&edition=fundamental","pubTime":"2025-06-30 11:25","pubTimestamp":1751253930,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250630:nASX49MLxK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nASXb0Bm4G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","OIL.AU"],"gpt_icon":0},{"id":"2545334450","title":"Optiscan Imaging Enters Collaboration Agreement with US Firm for Applications for Imaging Contrast Agent, Shares Jump 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545334450","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545334450?lang=en_us&edition=fundamental","pubTime":"2025-06-23 09:59","pubTimestamp":1750643944,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  entered into an exclusive collaboration agreement with Long Grove Pharmaceuticals to develop new intended applications for Long Grove's intravenous drug, fluorescein sodium, or AK-FLOUR, according to a Monday Australian bourse filing.AK-FLOUR is a contrast agent specifically used with Optiscan's current generation of fluorescence-based endomicroscopic imaging devices for surgical applications. The firms will develop new intended uses for the intravenous fluorescein sodium contrast agent.AK-FLOUR will be used exclusively in US clinical studies and trials with Optiscan's InVue device in a range of clinical applications, starting with breast surgery. Data from the collaboration studies will be used to support Optiscan's US Food and Drug Administration regulatory submissions for its InVue surgical device.Its shares jumped 9% in recent trading on Monday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2545452000","title":"BRIEF-Optiscan Imaging Signs Agreement With Long Grove Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2545452000","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545452000?lang=en_us&edition=fundamental","pubTime":"2025-06-23 09:37","pubTimestamp":1750642653,"startTime":"0","endTime":"0","summary":"BRIEF-Optiscan Imaging Signs Agreement With Long Grove PharmaceuticalsJune 23 (Reuters) - Optiscan Imaging Ltd OIL.AX:SIGNS AGREEMENT WITH LONG GROVE PHARMACEUTICALSUNDER DEAL, COS TO DEVELOP NEW INTE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nFWN3SN072:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2545456908","title":"Optiscan Imaging Ltd - Signs Agreement With Long Grove Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2545456908","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545456908?lang=en_us&edition=fundamental","pubTime":"2025-06-23 06:41","pubTimestamp":1750632117,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250622:nFWN3SN072:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2545456906","title":"Optiscan Imaging -  Under Deal, Cos to Develop New Intended Uses for Long Grove's Intravenous Fluorescein Sodium Contrast Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2545456906","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545456906?lang=en_us&edition=fundamental","pubTime":"2025-06-23 06:41","pubTimestamp":1750632117,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250622:nFWN3SN072:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","OIL.AU"],"gpt_icon":0},{"id":"2545456082","title":"ASX ALERT-Optiscan Signs Agreement with Long Grove Pharmaceuticals-OIL.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2545456082","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545456082?lang=en_us&edition=fundamental","pubTime":"2025-06-23 06:41","pubTimestamp":1750632111,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250622:nASX1Mc6LW","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250622:nASX3L1K3F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2542668893","title":"Optiscan Imaging to Showcase Veterinary Imaging Device InSpecta at US Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2542668893","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542668893?lang=en_us&edition=fundamental","pubTime":"2025-06-10 12:05","pubTimestamp":1749528344,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  will showcase its product InSpecta, a novel microscopic imaging device designed specifically for the veterinary medicine market segment, at the American College of Veterinary Internal Medicine conference in Kentucky to be held from June 19 to 21, according to a Tuesday Australian bourse filing.The device will be tested at the company's veterinary medicine partner institution, the University of Minnesota College of Veterinary Medicine, to help support regulatory submissions.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","OIL.AU"],"gpt_icon":0},{"id":"2538436876","title":"Optiscan Completes Minimum Viable Product Stage for Telepathology Streaming Software Project; Shares Rise 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538436876","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538436876?lang=en_us&edition=fundamental","pubTime":"2025-05-27 12:55","pubTimestamp":1748321726,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  completed the minimum viable product phase of its cloud-based telepathology streaming software platform project, according to a Tuesday filing with the Australian bourse.The company will now move to real-world testing and clinical rollout preparation, the filing said.Shares of the company rose almost 14% in recent Tuesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","OIL.AU","BK7007","XKO.AU","XJO.AU","SSI"],"gpt_icon":0},{"id":"2535798253","title":"Optiscan Imaging Working on Robotic-Compatible Digital Endomicroscopic Imaging System. Shares Fall 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535798253","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535798253?lang=en_us&edition=fundamental","pubTime":"2025-05-13 13:55","pubTimestamp":1747115741,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  said it is progressing the development of a digital confocal laser endomicroscopic imaging system for use in robotic surgery in collaboration with the Mayo Clinic, according to a Tuesday Australian bourse filing.The collaboration leveraged Optiscan's expertise in high-resolution endomicroscopic imaging technology and Mayo Clinic's leadership in robotic surgery and clinical care.The firms have made advancements as part of their 24-month co-development plan to design an imaging system tailored for robotic-assisted breast cancer surgeries.Its shares fell 9% in recent trading on Tuesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2535104752","title":"BUZZ-Australia's Optiscan Imaging gains on Mayo clinic collaboration progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2535104752","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535104752?lang=en_us&edition=fundamental","pubTime":"2025-05-13 10:53","pubTimestamp":1747104791,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Optiscan Imaging gains on Mayo clinic collaboration progress** Optiscan Imaging OIL.AX rises 6.82% to A$0.1175; marks biggest percentage gain since April 17** Imaging technologies maker and Mayo Clinic have come together to advance the development of a digital endomicroscopic imaging system for use in robotic surgery** Co says development plan on track and project's next phase will take place at the Mayo Clinic's Florida campus** OIL loses 29% this year, as of last close  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL4N3RL07O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2535404758","title":"BRIEF-Optiscan Imaging Says Progressing Robotic Surgery Collaboration With Mayo Clinic","url":"https://stock-news.laohu8.com/highlight/detail?id=2535404758","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535404758?lang=en_us&edition=fundamental","pubTime":"2025-05-13 09:29","pubTimestamp":1747099788,"startTime":"0","endTime":"0","summary":"BRIEF-Optiscan Imaging Says Progressing Robotic Surgery Collaboration With Mayo ClinicMay 13 (Reuters) - Optiscan Imaging Ltd OIL.AX:OPTISCAN PROGRESSES ROBOTIC SURGERY COLLABORATION WITH MAYO CLINICFurther company coverage: OIL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nFWN3RK2F3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","OIL.AU"],"gpt_icon":0},{"id":"2535739818","title":"Optiscan Imaging Ltd -  Optiscan Progresses Robotic Surgery Collaboration With Mayo Clinic","url":"https://stock-news.laohu8.com/highlight/detail?id=2535739818","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535739818?lang=en_us&edition=fundamental","pubTime":"2025-05-13 07:35","pubTimestamp":1747092959,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nFWN3RK2F3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2523934273","title":"BRIEF-Optiscan Imaging Darius Ooi Promoted To Chief Financial Officer Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2523934273","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523934273?lang=en_us&edition=fundamental","pubTime":"2025-03-31 09:34","pubTimestamp":1743384858,"startTime":"0","endTime":"0","summary":"BRIEF-Optiscan Imaging Darius Ooi Promoted To Chief Financial Officer RoleMarch 31 (Reuters) - Optiscan Imaging Ltd OIL.AX:DARIUS OOI PROMOTED TO CHIEF FINANCIAL OFFICER ROLEFurther company coverage: OIL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QC00F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2523931987","title":"Optiscan Imaging Promotes Finance Manager to CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2523931987","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523931987?lang=en_us&edition=fundamental","pubTime":"2025-03-31 09:17","pubTimestamp":1743383871,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  promoted its current finance manager Darius Ooi to the role of Chief Financial Officer after an operational review, according to a Monday Australian bourse filing.Belinda Williamson was appointed to the position of Chief Commercial Officer to lead its sales and marketing team.Its Chief Operating Officer Brendan Fafiani stepped down from this role to pursue other opportunities.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","OIL.AU"],"gpt_icon":0},{"id":"2523743984","title":"Optiscan Imaging  -  Darius Ooi Promoted to Chief Financial Officer Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2523743984","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523743984?lang=en_us&edition=fundamental","pubTime":"2025-03-31 06:19","pubTimestamp":1743373160,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250330:nFWN3QC00F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2521732476","title":"Investors push Optiscan Imaging (ASX:OIL) 11% lower this week, company's increasing losses might be to blame","url":"https://stock-news.laohu8.com/highlight/detail?id=2521732476","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521732476?lang=en_us&edition=fundamental","pubTime":"2025-03-24 10:13","pubTimestamp":1742782424,"startTime":"0","endTime":"0","summary":"It hasn't been the best quarter for Optiscan Imaging Limited  shareholders, since the share price has fallen 29% in that time. But that doesn't change the fact that the returns over the last half decade have been spectacular. In fact, during that period, the share price climbed 400%. Impressive!So it might be that some shareholders are taking profits after good performance. Of course what matters most is whether the business can improve itself sustainably, thus justifying a higher price.In light of the stock dropping 11% in the past week, we want to investigate the longer term story, and see if fundamentals have been the driver of the company's positive five-year return.Optiscan Imaging isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Shareholders of unprofitable companies usually desire strong revenue growth. Some companies are willing to postpone profitability to grow revenue faster, but in that c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-push-optiscan-imaging-asx-021344578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["OIL","ISBC","BK4211","OIL.AU","BK7007"],"gpt_icon":0},{"id":"2512473721","title":"Optiscan Imaging Launches New Medical Imaging Device For Pathology; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512473721","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512473721?lang=en_us&edition=fundamental","pubTime":"2025-02-19 12:26","pubTimestamp":1739939211,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  revealed its next-generation microscopic medical imaging device InForm specifically designed for pathology workflows, according to a Wednesday filing with the Australian bourse.The device can be used in a variety of pathology settings, most notably in laboratory medicine, pathology practice, point-of-care, and digital pathology, the filing added.The new device expands the company into the pathology market, per the filing.Company shares rose almost 7% in recent Wednesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2510510908","title":"Australian Vanadium Leads The Charge Among 3 ASX Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2510510908","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510510908?lang=en_us&edition=fundamental","pubTime":"2025-02-10 15:11","pubTimestamp":1739171471,"startTime":"0","endTime":"0","summary":"The Australian market recently faced a slight downturn, with the ASX200 closing down 0.34% amid concerns over potential trade tensions sparked by President Trump's tariff threats. Despite these broader market uncertainties, penny stocks continue to attract attention for their potential to uncover hidden value in smaller or newer companies. Though the term 'penny stock' may seem outdated, it still signifies opportunities where strong financials and growth prospects can lead to significant...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-gdm/great-divide-mining-shares/news/australian-vanadium-leads-the-charge-among-3-asx-penny-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MXI.AU","ANG.AU","EVO.AU","HLO.AU","OIL.AU","BK7070","BK7055","BK7048","DSK.AU","XJO.AU","BK7007","XAO.AU","AVL","BK7077","LBL.AU","AVL.AU","BK7088","BK7096","BK7132","BK7045","SHA.AU","BK7095","GDM.AU","VLS.AU","EZZ.AU","IGL.AU","BK7128","XKO.AU"],"gpt_icon":0},{"id":"2509570384","title":"Here's Why We're Not Too Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2509570384","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509570384?lang=en_us&edition=fundamental","pubTime":"2025-02-08 07:25","pubTimestamp":1738970735,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com?So, the natural question for Optiscan Imaging  shareholders is whether they should be concerned by its rate of cash burn. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth . We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.Check out our latest analysis for Optiscan Imaging. Does Optiscan Imaging Have A Long Cash Runway?How Is Optiscan Imaging's Cash Burn Changing Over Time?Optiscan Imaging's cash burn of AU$5.8m is about 4.2% of its AU$138m market capitalisation. That's a low pro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-were-not-too-232535835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["OIL","OIL.AU","BK7007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}